-
Cancer Today Editors’ Picks: 2022The editors share some of the top stories reported in Cancer Today in the past year.
-
My Name is Mom. And I Have Cancer.Author Tara Rolle shares the challenge of staying fully present as a parent during cancer treatment and in the years that followed.
by Tara Rolle
-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast CancerThe new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
-
Pregnancy After a Breast Cancer DiagnosisStudy finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
by Thomas Celona
-
Disparities in Breast Cancer Outcomes for Black Women Despite Similar Recurrence ScoresBlack breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
by Eric Fitzsimmons
-
A ‘Revolution’ in Cancer ResearchAACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
-
Finding Your NicheSupport groups offer community for people with cancer in a world that doesn’t understand their experience.
by Carly Flumer
-
Making Informed Consent AccessibleConfusing informed consent forms are a common barrier to clinical trial participation. Researchers ask how they can be better designed for patients.
by Sandra Gordon
-
Keep That Colonoscopy AppointmentExperts weigh in on a recent study appearing to show that colonoscopy had lower-than-expected efficacy for preventing colorectal cancer.
by Pamela Rafalow Grossman
-
What We Know About Ultraprocessed Foods and Cancer RiskResearch has linked highly processed foods like deli meat to a higher risk of colorectal cancer in men.
by Jon Kelvey
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
-
Pediatric Cancer’s AftershocksNew research highlights approaches that could provide better long-term quality of life for childhood cancer survivors.
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
